Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diane Solomon

Showing results (61-70 of 95) with videos related to

Pageof 10
Sort By:
Obstetrics and Gynecology|August 2, 2006
Number of cervical biopsies and sensitivity of colposcopyJulia C Gage, Vivien W Hanson, Kim Abbey, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2006
Human papillomavirus testing following loop electrosurgical excision procedure identifies women at risk for posttreatment cervical intraepithelial neoplasia grade 2 or 3 diseaseAimée R Kreimer, Richard S Guido, Diane Solomon, et al.
Journal of the National Cancer Institute|January 19, 2006
Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS)Shalini L Kulasingam, Jane J Kim, William F Lawrence, et al.
JAMA|April 23, 2002
The 2001 Bethesda System: terminology for reporting results of cervical cytologyDiane Solomon, Diane Davey, Robert Kurman, et al.
Obstetrics and Gynecology|May 3, 2013
2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursorsL Stewart Massad, Mark H Einstein, Warner K Huh, et al.
BMJ (Clinical Research Ed.)|March 4, 2010
Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomised controlled trialsSholom Wacholder, Bingshu Eric Chen, Allen Wilcox, et al.
Journal of Lower Genital Tract Disease|March 23, 2013
2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursorsL Stewart Massad, Mark H Einstein, Warner K Huh, et al.
Journal of the National Cancer Institute|January 20, 2005
A study of the impact of adding HPV types to cervical cancer screening and triage testsMark Schiffman, Michelle J Khan, Diane Solomon, et al.
Obstetrics and Gynecology|February 3, 2004
Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screeningThomas C Wright, Mark Schiffman, Diane Solomon, et al.
BMJ (Clinical Research Ed.)|July 30, 2009
Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort studyPhilip E Castle, Ana Cecilia Rodríguez, Robert D Burk, et al.
Pageof 10

Showing results (61-70 of 95) with videos related to

Sort By:
Pageof 10
Obstetrics and Gynecology|August 2, 2006
Number of cervical biopsies and sensitivity of colposcopyJulia C Gage, Vivien W Hanson, Kim Abbey, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2006
Human papillomavirus testing following loop electrosurgical excision procedure identifies women at risk for posttreatment cervical intraepithelial neoplasia grade 2 or 3 diseaseAimée R Kreimer, Richard S Guido, Diane Solomon, et al.
Journal of the National Cancer Institute|January 19, 2006
Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS)Shalini L Kulasingam, Jane J Kim, William F Lawrence, et al.
JAMA|April 23, 2002
The 2001 Bethesda System: terminology for reporting results of cervical cytologyDiane Solomon, Diane Davey, Robert Kurman, et al.
Obstetrics and Gynecology|May 3, 2013
2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursorsL Stewart Massad, Mark H Einstein, Warner K Huh, et al.
BMJ (Clinical Research Ed.)|March 4, 2010
Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomised controlled trialsSholom Wacholder, Bingshu Eric Chen, Allen Wilcox, et al.
Journal of Lower Genital Tract Disease|March 23, 2013
2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursorsL Stewart Massad, Mark H Einstein, Warner K Huh, et al.
Journal of the National Cancer Institute|January 20, 2005
A study of the impact of adding HPV types to cervical cancer screening and triage testsMark Schiffman, Michelle J Khan, Diane Solomon, et al.
Obstetrics and Gynecology|February 3, 2004
Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screeningThomas C Wright, Mark Schiffman, Diane Solomon, et al.
BMJ (Clinical Research Ed.)|July 30, 2009
Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort studyPhilip E Castle, Ana Cecilia Rodríguez, Robert D Burk, et al.
Pageof 10